Silo Pharma (SILO) Total Liabilities (2010 - 2026)
Silo Pharma (SILO) posted Total Liabilities of $1.3 million for Q1 2026, up 2.82% sequentially from $1.3 million in Q4 2025, and down 29.25% YoY from $1.9 million in Q1 2025.
Silo Pharma (SILO) Total Liabilities (2010 - 2026) Analysis & Trends
Silo Pharma has reported Total Liabilities for 14 years, with the latest figure at $1.3 million in Q1 2026.
- Quarterly Total Liabilities fell 29.25% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 29.25% YoY) and the FY2025 annual result came in at $1.3 million, down 45.34% from the prior year.
- Total Liabilities grew to $1.3 million in Q1 2026 per SILO's latest filing, from $1.3 million in the prior quarter.
- Over five years, Total Liabilities peaked at $2.4 million in Q4 2024 and troughed at $1.2 million in Q2 2022.
- A 5-year average of $1.6 million and a median of $1.6 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities jumped 66.56% in 2023, then tumbled 45.34% in 2025.
- Over 5 years, Total Liabilities stood at $1.3 million in 2022, then gained by 20.52% to $1.6 million in 2023, then surged by 51.51% to $2.4 million in 2024, then sank by 45.34% to $1.3 million in 2025, then grew by 2.82% to $1.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $1.3 million, $1.3 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 10.03 Bn |
| 10 | Silo Pharma | 2.93 Mn | 2.93 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.34 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.57 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 1.95 Mn |
| Mar 31, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.43 Mn |
| Sep 30, 2021 | 1.24 Mn |